Stratos Wealth Partners’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-18,220
Closed -$64.7K – 1747
2026
Q1
$64.7K Buy
18,220
+2,200
+14% +$9.01K ﹤0.01% 1598
2025
Q4
$75.6K Sell
16,020
-4,685
-23% -$20.9K ﹤0.01% 1564
2025
Q3
$99.2K Buy
20,705
+8,685
+72% +$34.2K ﹤0.01% 1517
2025
Q2
$29K Buy
+12,020
New +$29.6K ﹤0.01% 1406
2024
Q4
– Sell
-55,585
Closed -$399K – 1511
2024
Q3
$399K Buy
+55,585
New +$395K 0.01% 1018

Other funds holding MSOS

Stratos Wealth Partners's MSOS Position: Q2 2026 in Review

Stratos Wealth Partners sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q2 2026, closing a stake of 18,220 shares — an estimated $64.7K sold.

Stratos Wealth Partners first reported a position in MSOS in Q3 2024 and held it in 5 quarters. The position peaked at $399K in Q3 2024. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Stratos Wealth Partners reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q2 2026 after selling out during the quarter.
  • Stratos Wealth Partners sold 18,220 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $64.7K.
  • Stratos Wealth Partners first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2024 and held it in 5 quarters.
  • Stratos Wealth Partners's AdvisorShares Pure US Cannabis ETF position peaked at $399K in Q3 2024.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.